Literature DB >> 11390273

In vivo 1H MR spectra analysis by means of second derivative method.

M Sokół1.   

Abstract

Short echo time (TE) in vivo PRESS 1H MR spectra (2 T, TE=35 ms) of normal brain were fitted in the frequency domain using the second derivative method. In this approach, local maxima and hidden peaks are found as local minima of spectrum second derivative. The Lorentzian robust minimisation procedure (referred to as maximum likelihood or m-estimate fitting) using Levenburg-Marquardt non-linear fitting engine was applied. Spectral lines were approximated under the assumption of the mixed Lorentzian/Gaussian lineshapes. The same procedure was applied to 18 proton spectra. The number of peaks found within the range of 0.74/4.2 parts per million (ppm) was 52+/-3 and their positions were almost the same. The fitted lines were assigned on the basis of the J-pattern recalculated for the field strength of 2 T and by comparing the chemical shifts with the shifts in the single compound spectra. The ratios of main metabolites, such as NAA/Cr, Cho/Cr, Cho/NAA and mI/Cr, are in accord with those obtained earlier using the software supplied with the MR imager and the absolute concentrations of N-acetylaspartate (NAA), choline containing compounds (Cho), myoInositol (mI), glucose (Glc) and glutamate (Glu) obtained from the fit agree with those reported in literature, which confirms the usefulness of the second derivative method in routine analyses of 1H MR brain spectra.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11390273     DOI: 10.1016/s1352-8661(01)00114-4

Source DB:  PubMed          Journal:  MAGMA        ISSN: 0968-5243            Impact factor:   2.310


  7 in total

1.  Improved quantification of in vivo 1H NMR spectra by optimization of signal acquisition and processing and by incorporation of prior knowledge into the spectral fitting.

Authors:  A A de Graaf; W M Bovée
Journal:  Magn Reson Med       Date:  1990-08       Impact factor: 4.668

2.  Absolute metabolite quantification by in vivo NMR spectroscopy: III. Multicentre 1H MRS of the human brain addressed by one and the same data-analysis protocol.

Authors:  R De Beer; B Barbiroli; G Gobbi; A Knijn; H Kügel; K W Langenberger; I Tkác; S Topp
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

3.  Absolute metabolite quantification by in vivo NMR spectroscopy: II. A multicentre trial of protocols for in vivo localised proton studies of human brain.

Authors:  S F Keevil; B Barbiroli; J C Brooks; E B Cady; R Canese; P Carlier; D J Collins; P Gilligan; G Gobbi; J Hennig; H Kügel; M O Leach; D Metzler; V Mlynárik; E Moser; M C Newbold; G S Payne; P Ring; J N Roberts; I J Rowland; T Thiel; I Tkác; S Topp; H J Wittsack; F Podo
Journal:  Magn Reson Imaging       Date:  1998-11       Impact factor: 2.546

4.  Automated single-voxel proton MRS: technical development and multisite verification.

Authors:  P G Webb; N Sailasuta; S J Kohler; T Raidy; R A Moats; R E Hurd
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

5.  Time and frequency domain analysis of NMR data compared: an application to 1D 1H spectra of lipoproteins.

Authors:  A van den Boogaart; M Ala-Korpela; J Jokisaari; J R Griffiths
Journal:  Magn Reson Med       Date:  1994-04       Impact factor: 4.668

6.  Quality assessment in in vivo NMR spectroscopy: II. A protocol for quality assessment. EEC Concerted Research Project.

Authors:  W M Bovée; S F Keevil; M O Leach; F Podo
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

7.  Quality assessment in in vivo NMR spectroscopy: IV. A multicentre trial of test objects and protocols for performance assessment in clinical NMR spectroscopy.

Authors:  S F Keevil; B Barbiroli; D J Collins; E R Danielsen; J Hennig; O Henriksen; M O Leach; R Longo; M Lowry; C Moore
Journal:  Magn Reson Imaging       Date:  1995       Impact factor: 2.546

  7 in total
  1 in total

1.  Tolerability and toxicity of prophylactic cranial irradiation in patients with non-small cell lung cancer - Results of a phase II study (with estimation of hematological toxicity, pituitary function and magnetic resonance spectra changes).

Authors:  Marzena Gawkowska-Suwińska; Sławomir Blamek; Alicja Heyda; Lukasz Boguszewicz; Anna Cichoń; Lukasz Zarudzki; Elżbieta Nowicka; Katarzyna Behrendt; Beata Smolska-Ciszewska; Grzegorz Plewicki; Aleksander Zajusz; Rafał Tarnawski
Journal:  Rep Pract Oncol Radiother       Date:  2014-07-17
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.